Concepedia

Bryan Oronsky

BO

58

Publications

1.4K

Citations

20

H-Index

1991

Active since

Affiliations

University of California San Diego(Current)

Walter Reed National Military Medical Center

Stanford University

La Jolla Bioengineering Institute

Epicentre (South Africa)

Bryan Oronsky is an author at University of California San Diego specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1991–2023

58

Publications

58

Dinitroazetidines Are a Novel Class of Anticancer Agents and Hypoxia-Activated Radiation Sensitizers Developed from Highly Energetic Materials

Shoucheng Ning, Mark D. Bednarski, Bryan Oronsky et al. · Cancer Research · 2012 · 101 citations

Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study

Tony Reid, Bryan Oronsky, Jan Scicinski et al. · The Lancet Oncology · 2015 · 90 citations

, , +7

Six Degrees of Separation: The Oxygen Effect in the Development of Radiosensitizers

Bryan Oronsky, Susan J. Knox, Jan Scicinski · Translational Oncology · 2011 · 89 citations · Full text

A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells

Deepika Sharma Das, Arghya Ray, Abhishek Das et al. · Leukemia · 2016 · 84 citations · Full text

, , +6

Epigenetic effects of RRx-001: a possible unifying mechanism of anticancer activity

Hongjuan Zhao, Shoucheng Ning, Jan Scicinski et al. · Oncotarget · 2015 · 52 citations · Full text

Rows per page

1–5 of 58